Skip to content

Effect of Ayurvedic medicine in ADHD in children of age 6 to 12 years

Randomized controlled trial to evaluate the efficacy of Dheeradi Ghrita in the management of Attention Deficit Hyperactivity Disorder(ADHD) in children of age group 6 to 12 years - Nil

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/06/089402
Enrollment
60
Registered
2025-06-24
Start date
Unknown
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F909- Attention-deficit hyperactivity disorder, unspecified type

Interventions

None listed

Sponsors

Anjali Pratap Thawrani
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age group between 6 to 12 yrs. Patient irrespective of their gender, religion and socioeconomic status. Patients having Symptoms of ADHD for at least last 6 months. Patients that fit in DSM IV criteria for diagnosis. Children with no other neurological condition like mental retardation, down syndrome, microcephaly, etc.

Exclusion criteria

Exclusion criteria: Any serious neurological disease diagnosed earlier like cerebral palsy, mental retardation, microcephaly. Any kind of systemic disease or chronic systemic disease like nephrotic syndrome, type 1 diabetes melitus. disobedient parents.

Design outcomes

Primary

MeasureTime frame
To study the effect of Dheeradi Ghrita in ADHDTimepoint: 15 days

Secondary

MeasureTime frame
To understand the disease ADHD in detail. To find out ayurvedic correlation of disease with doshas and dushya. To understand samprapti of disease. To find better treatment options for ADHD. To create awareness of disease ADHD. Timepoint: 15 days

Countries

India

Contacts

Public ContactVd Rajesh Prabhakar Bholane

Siddhakala ayurved mahavidyalaya

drrajeshbholane@gmail.com9822334742

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026